Harrow Health, Inc.
Price Action
Technical Summary
CONSOLIDATINGHarrow Health, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings contraction of 48% provides fundamental context to the price action. Investors should exercise caution due to high volatility (66% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $36.13 | +17.37% | ABOVE |
| 50 SMA | $36.77 | +15.35% | ABOVE |
| 100 SMA | $39.17 | +8.27% | ABOVE |
| 150 SMA | $41.39 | +2.46% | ABOVE |
| 200 SMA | $41.21 | +2.90% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HROW in an uptrend right now?
HROW has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HROW overbought or oversold?
HROW's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is HROW outperforming the market?
HROW has a Relative Strength (RS) Rating of 46 out of 99. HROW is currently lagging the broader market.
Where is HROW in its 52-week range?
HROW is trading at $42.41, which is 77% of its 52-week high ($54.85) and 53% above its 52-week low ($28.54).
How volatile is HROW?
HROW has a Beta of 1.77 and 52-week volatility of 66%. It's more volatile than the S&P 500 - expect bigger swings.